$18.64
3.92% day before yesterday
Nasdaq, Nov 01, 09:00 pm CET
ISIN
US78573L1061
Symbol
SBRA

Sabra Health Care REIT, Inc. Target price 2024 - Analyst rating & recommendation

Sabra Health Care REIT, Inc. Classifications & Recommendation:

Buy
57%
Hold
43%

Sabra Health Care REIT, Inc. Price Target

Target Price $19.23
Price $18.64
Potential
Number of Estimates 11
11 Analysts have issued a price target Sabra Health Care REIT, Inc. 2025 . The average Sabra Health Care REIT, Inc. target price is $19.23. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 14 analysts: 8 Analysts recommend Sabra Health Care REIT, Inc. to buy, 6 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sabra Health Care REIT, Inc. stock has an average upside potential 2025 of . Most analysts recommend the Sabra Health Care REIT, Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 655.85 682.75
6.10% 4.10%
EBITDA Margin 63.76% 63.35%
8.45% 0.64%
Net Margin 2.14% 18.19%
116.63% 748.77%

9 Analysts have issued a sales forecast Sabra Health Care REIT, Inc. 2024 . The average Sabra Health Care REIT, Inc. sales estimate is

$683m
Unlock
. This is
0.69% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$704m 3.81%
Unlock
, the lowest is
$659m 2.79%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $656m 6.10%
2024
$683m 4.10%
Unlock
2025
$720m 5.43%
Unlock
2026
$757m 5.16%
Unlock
2027
$851m 12.49%
Unlock
2028
$899m 5.54%
Unlock

9 Analysts have issued an Sabra Health Care REIT, Inc. EBITDA forecast 2024. The average Sabra Health Care REIT, Inc. EBITDA estimate is

$432m
Unlock
. This is
0.17% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$459m 6.29%
Unlock
, the lowest is
$426m 1.26%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $418m 2.86%
2024
$432m 3.43%
Unlock
2025
$458m 5.80%
Unlock
2026
$470m 2.65%
Unlock
2027
$459m 2.30%
Unlock

EBITDA Margin

2023 63.76% 8.45%
2024
63.35% 0.64%
Unlock
2025
63.57% 0.35%
Unlock
2026
62.05% 2.39%
Unlock
2027
53.89% 13.15%
Unlock

6 Sabra Health Care REIT, Inc. Analysts have issued a net profit forecast 2024. The average Sabra Health Care REIT, Inc. net profit estimate is

$124m
Unlock
. This is
140.91% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$129m 149.99%
Unlock
, the lowest is
$117m 127.27%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $14.1m 117.65%
2024
$124m 783.35%
Unlock
2025
$160m 28.93%
Unlock
2026
$170m 6.10%
Unlock

Net Margin

2023 2.14% 116.63%
2024
18.19% 748.77%
Unlock
2025
22.24% 22.26%
Unlock
2026
22.44% 0.90%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 0.06 0.53
117.65% 783.33%
P/E 35.17
EV/Sales 9.96

6 Analysts have issued a Sabra Health Care REIT, Inc. forecast for earnings per share. The average Sabra Health Care REIT, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.53
Unlock
. This is
140.91% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.55 150.00%
Unlock
, the lowest is
$0.50 127.27%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $0.06 117.65%
2024
$0.53 783.33%
Unlock
2025
$0.68 28.30%
Unlock
2026
$0.73 7.35%
Unlock

P/E ratio

Current 83.48 432.59%
2024
35.17 57.87%
Unlock
2025
27.28 22.43%
Unlock
2026
25.71 5.76%
Unlock

Based on analysts' sales estimates for 2024, the Sabra Health Care REIT, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 10.03 14.37%
2024
9.96 0.69%
Unlock
2025
9.45 5.15%
Unlock
2026
8.98 4.91%
Unlock
2027
7.99 11.10%
Unlock
2028
7.57 5.25%
Unlock

P/S ratio

Current 6.44 30.86%
2024
6.40 0.68%
Unlock
2025
6.07 5.15%
Unlock
2026
5.77 4.91%
Unlock
2027
5.13 11.10%
Unlock
2028
4.86 5.25%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today